Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization

Cancer Cell

Volumn 33, Issue 3, 2018, Pages 347-354

  Schild, Tanya ^a   Low, Vivien ^a   Blenis, John ^a   Gomes, Ana P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

cancer; metabolism; metastasis; tissue tropism

Indexed keywords

ACETIC ACID; GLUCOSE;

ADIPOCYTE; BONE METASTASIS; BRAIN METASTASIS; CANCER CELL; CANCER STAGING; CARCINOGENESIS; CELL SURVIVAL; HUMAN; LIVER METASTASIS; LUNG METASTASIS; METABOLISM; METASTASIS; NONHUMAN; OMENTUM; OXIDATIVE STRESS; PERITONEUM METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; TROPISM; TUMOR INVASION; TUMOR MICROENVIRONMENT; ADAPTATION; ANIMAL; BRAIN; LIVER; LUNG; PATHOLOGY; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN; HUMANS; LIVER; LUNG; NEOPLASM METASTASIS; TUMOR MICROENVIRONMENT;

EID: 85042867715     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2018.02.001     Document Type: Review

References (72)

1. Albrecht, J., Sidoryk-Węgrzynowicz, M., Zielińska, M., Aschner, M., Roles of glutamine in neurotransmission. Neuron Glia Biol. 6 (2010), 263–276.
2. Alvarado, A., Arce, I., Metabolic functions of the lung, disorders and associated pathologies. J. Clin. Med. Res. 8 (2016), 689–700.
3. Andrzejewski, S., Klimcakova, E., Johnson, R.M., Tabaries, S., Annis, M.G., McGuirk, S., Northey, J.J., Chenard, V., Sriram, U., Papadopoli, D.J., et al. PGC-1alpha promotes breast cancer metastasis and confers bioenergetic flexibility against metabolic drugs. Cell Metab. 26 (2017), 778–787.e5.
4. Brastianos, P.K., Carter, S.L., Santagata, S., Cahill, D.P., Taylor-Weiner, A., Jones, R.T., Van Allen, E.M., Lawrence, M.S., Horowitz, P.M., et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 5 (2015), 1164–1177.
5. Carlinfante, G., Vassiliou, D., Svensson, O., Wendel, M., Heinegard, D., Andersson, G., Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin. Exp. Metastasis 20 (2003), 437–444.
6. Chen, J., Lee, H.J., Wu, X., Huo, L., Kim, S.J., Xu, L., Wang, Y., He, J., Bollu, L.R., Gao, G., et al. Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. Cancer Res. 75 (2015), 554–565.
7. Choe, S.S., Huh, J.Y., Hwang, I.J., Kim, J.I., Kim, J.B., Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front. Endocrinol. (Lausanne), 7, 2016, 30.
8. Christen, S., Lorendeau, D., Schmieder, R., Broekaert, D., Metzger, K., Veys, K., Elia, I., Buescher, J.M., Orth, M.F., Davidson, S.M., et al. Breast cancer-derived lung metastases show increased pyruvate carboxylase-dependent anaplerosis. Cell Rep. 17 (2016), 837–848.
9. da Silva, R.P., Nissim, I., Brosnan, M.E., Brosnan, J.T., Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E256–E261.
10. Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T.W., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23 (2013), 316–331.
11. Dupuy, F., Tabaries, S., Andrzejewski, S., Dong, Z., Blagih, J., Annis, M.G., Omeroglu, A., Gao, D., Leung, S., Amir, E., et al. PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab. 22 (2015), 577–589.
12. Ebert, D., Haller, R.G., Walton, M.E., Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J. Neurosci. 23 (2003), 5928–5935.
13. Elia, I., Broekaert, D., Christen, S., Boon, R., Radaelli, E., Orth, M.F., Verfaillie, C., Grunewald, T.G.P., Fendt, S.M., Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat. Commun., 8, 2017, 15267.
14. Erbsloh, F., Bernsmeier, A., Hillesheim, H., The glucose consumption of the brain & its dependence on the liver. Arch. Psychiatr. Nervenkr. Z. Gesamte Neurol. Psychiatr. 196 (1958), 611–626.
15. Gomes, A.P., Blenis, J., A nexus for cellular homeostasis: the interplay between metabolic and signal transduction pathways. Curr. Opin. Biotechnol. 34 (2015), 110–117.
16. Guimaraes-Ferreira, L., Role of the phosphocreatine system on energetic homeostasis in skeletal and cardiac muscles. Einstein (Sao Paulo) 12 (2014), 126–131.
17. Hojman, P., Gehl, J., Christensen, J.F., Pedersen, B.K., Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 27 (2017), 10–21.
18. Holmes, M.D., Chen, W.Y., Feskanich, D., Kroenke, C.H., Colditz, G.A., Physical activity and survival after breast cancer diagnosis. JAMA 293 (2005), 2479–2486.
19. Hou, X., Wu, X., Huang, P., Zhan, J., Zhou, T., Ma, Y., Qin, T., Luo, R., Feng, Y., Xu, Y., et al. Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma. Int. J. Cancer 137 (2015), 1672–1678.
20. Iwamoto, T., Mamiya, N., Masushige, S., Kida, S., PLCgamma2 activates CREB-dependent transcription in PC12 cells through phosphorylation of CREB at serine 133. Cytotechnology 47 (2005), 107–116.
21. Jiao, L., Zhang, H.L., Li, D.D., Yang, K.L., Tang, J., Li, X., Ji, J., Yu, Y., Wu, R.Y., Ravichandran, S., et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy, 2017, 10.1080/15548627.2017.1381804.
22. Kahles, F., Findeisen, H.M., Bruemmer, D., Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes. Mol. Metab. 3 (2014), 384–393.
23. Kamarajugadda, S., Stemboroski, L., Cai, Q., Simpson, N.E., Nayak, S., Tan, M., Lu, J., Glucose oxidation modulates anoikis and tumor metastasis. Mol. Cell. Biol. 32 (2012), 1893–1907.
24. Kenfield, S.A., Stampfer, M.J., Giovannucci, E., Chan, J.M., Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J. Clin. Oncol. 29 (2011), 726–732.
25. Kruger, T.E., Miller, A.H., Godwin, A.K., Wang, J., Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers. Crit. Rev. Oncol. Hematol. 89 (2014), 330–341.
26. LeBleu, V.S., O'Connell, J.T., Gonzalez Herrera, K.N., Wikman, H., Pantel, K., Haigis, M.C., de Carvalho, F.M., Damascena, A., Domingos Chinen, L.T., et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 16 (2014), 992–1003 1–15.
27. Lehuédé C., Dupuy, F., Rabinovitch, R., Jones, R.G., Siegel, P.M., Metabolic plasticity as a determinant of tumor growth and metastasis. Cancer Res. 76 (2016), 5201–5208.
28. Lemma, S., Di Pompo, G., Porporato, P.E., Sboarina, M., Russell, S., Gillies, R.J., Baldini, N., Sonveaux, P., Avnet, S., MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: a new rationale for the pathogenesis of osteolytic bone metastases. Biochim. Biophys. Acta 1863 (2017), 3254–3264.
29. Lin, Y.H., Wu, M.H., Huang, Y.H., Yeh, C.T., Cheng, M.L., Chi, H.C., Tsai, C.Y., Chung, I.H., Chen, C.Y., Lin, K.H., Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Hepatology 67 (2017), 188–203.
30. Liu, M., Quek, L.E., Sultani, G., Turner, N., Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma. Cancer Metab., 4, 2016, 19.
31. Loo, J.M., Scherl, A., Nguyen, A., Man, F.Y., Weinberg, E., Zeng, Z., Saltz, L., Paty, P.B., Tavazoie, S.F., Extracellular metabolic energetics can promote cancer progression. Cell 160 (2015), 393–406.
32. Lu, J., Tan, M., Cai, Q., The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 356 (2015), 156–164.
33. Magistretti, P.J., Allaman, I., A cellular perspective on brain energy metabolism and functional imaging. Neuron 86 (2015), 883–901.
34. Mardis, E.R., Ding, L., Dooling, D.J., Larson, D.E., McLellan, M.D., Chen, K., Koboldt, D.C., Fulton, R.S., Delehaunty, K.D., McGrath, S.D., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361 (2009), 1058–1066.
35. Martinez-Outschoorn, U.E., Pavlides, S., Howell, A., Pestell, R.G., Tanowitz, H.B., Sotgia, F., Lisanti, M.P., Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int. J. Biochem. Cell Biol. 43 (2011), 1045–1051.
36. Mashimo, T., Pichumani, K., Vemireddy, V., Hatanpaa, K.J., Singh, D.K., Sirasanagandla, S., Nannepaga, S., Piccirillo, S.G., Kovacs, Z., Foong, C., et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159 (2014), 1603–1614.
37. Mehlen, P., Puisieux, A., Metastasis: a question of life or death. Nat. Rev. Cancer 6 (2006), 449–458.
38. Meyerhardt, J.A., Giovannucci, E.L., Holmes, M.D., Chan, A.T., Chan, J.A., Colditz, G.A., Fuchs, C.S., Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24 (2006), 3527–3534.
39. Moore, S.C., Lee, I.M., Weiderpass, E., Campbell, P.T., Sampson, J.N., Kitahara, C.M., Keadle, S.K., Arem, H., Berrington de Gonzalez, A., Hartge, P., et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern. Med. 176 (2016), 816–825.
40. Nagarajan, A., Malvi, P., Wajapeyee, N., Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2 (2016), 365–377.
41. Nieman, K.M., Kenny, H.A., Penicka, C.V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M.R., Romero, I.L., Carey, M.S., Mills, G.B., Hotamisligil, G.S., et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17 (2011), 1498–1503.
42. Obenauf, A.C., Massague, J., Surviving at a distance: organ specific metastasis. Trends Cancer 1 (2015), 76–91.
43. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321 (2008), 1807–1812.
44. Pascual, G., Avgustinova, A., Mejetta, S., Martin, M., Castellanos, A., Attolini, C.S., Berenguer, A., Prats, N., Toll, A., Hueto, J.A., et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541 (2017), 41–45.
45. Pavlova, N.N., Thompson, C.B., The emerging hallmarks of cancer metabolism. Cell Metab. 23 (2016), 27–47.
46. Pollari, S., Kakonen, S.M., Edgren, H., Wolf, M., Kohonen, P., Sara, H., Guise, T., Nees, M., Kallioniemi, O., Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res. Treat. 125 (2011), 421–430.
47. Pusch, O., Soucek, T., Hengstschlager-Ottnad, E., Bernaschek, G., Hengstschlager, M., Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase. DNA Cell Biol. 16 (1997), 737–747.
48. Rodrigues, L.R., Teixeira, J.A., Schmitt, F.L., Paulsson, M., Lindmark-Mansson, H., The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol. Biomarkers Prev. 16 (2007), 1087–1097.
49. Romero-Garcia, S., Moreno-Altamirano, M.M., Prado-Garcia, H., Sanchez-Garcia, F.J., Lactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Front. Immunol., 7, 2016, 52.
50. Rucci, N., Teti, A., Osteomimicry: how tumor cells try to deceive the bone. Front. Biosci. (Schol. Ed.) 2 (2010), 907–915.
51. Scheja, L., Makowski, L., Uysal, K.T., Wiesbrock, S.M., Shimshek, D.R., Meyers, D.S., Morgan, M., Parker, R.A., Hotamisligil, G.S., Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes 48 (1999), 1987–1994.
52. Sellers, K., Fox, M.P., Bousamra, M. 2nd, Slone, S.P., Higashi, R.M., Miller, D.M., Wang, Y., Yan, J., Yuneva, M.O., Deshpande, R., et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J. Clin. Invest. 125 (2015), 687–698.
53. Shaul, Y.D., Freinkman, E., Comb, W.C., Cantor, J.R., Tam, W.L., Thiru, P., Kim, D., Kanarek, N., Pacold, M.E., Chen, W.W., et al. Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition. Cell 158 (2014), 1094–1109.
54. Shi, Z., Mirza, M., Wang, B., Kennedy, M.A., Weber, G.F., Osteopontin-a alters glucose homeostasis in anchorage-independent breast cancer cells. Cancer Lett. 344 (2014), 47–53.
55. Shim, H., Dolde, C., Lewis, B.C., Wu, C.S., Dang, G., Jungmann, R.A., Dalla-Favera, R., Dang, C.V., c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94 (1997), 6658–6663.
56. Shiozawa, Y., Eber, M.R., Berry, J.E., Taichman, R.S., Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors. Bonekey Rep., 4, 2015, 689.
57. Shroff, E.H., Eberlin, L.S., Dang, V.M., Gouw, A.M., Gabay, M., Adam, S.J., Bellovin, D.I., Tran, P.T., Philbrick, W.M., Garcia-Ocana, A., et al. MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism. Proc. Natl. Acad. Sci. USA 112 (2015), 6539–6544.
58. Song, K., Kwon, H., Han, C., Zhang, J., Dash, S., Lim, K., Wu, T., Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122. Oncotarget 6 (2015), 40822–40835.
59. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jager, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127 (2006), 397–408.
60. Stresing, V., Baltziskueta, E., Rubio, N., Blanco, J., Arriba, M.C., Valls, J., Janier, M., Clezardin, P., Sanz-Pamplona, R., Nieva, C., et al. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene 32 (2013), 724–735.
61. Tanaka, Y., Nakayamada, S., Okada, Y., Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr. Drug Targets Inflamm. Allergy 4 (2005), 325–328.
62. Thompson, H.J., Jiang, W., Zhu, Z., Candidate mechanisms accounting for effects of physical activity on breast carcinogenesis. IUBMB Life 61 (2009), 895–901.
63. Valavanidis, A., Vlachogianni, T., Fiotakis, K., Loridas, S., Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int. J. Environ. Res. Public Health 10 (2013), 3886–3907.
64. van den Heuvel, A.P., Jing, J., Wooster, R.F., Bachman, K.E., Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol. Ther. 13 (2012), 1185–1194.
65. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (2009), 1029–1033.
66. Ward, P.S., Thompson, C.B., Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21 (2012), 297–308.
67. Wellen, K.E., Thompson, C.B., A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13 (2012), 270–276.
68. Ye, X., Weinberg, R.A., Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 25 (2015), 675–686.
69. Yin, C., He, D., Chen, S., Tan, X., Sang, N., Exogenous pyruvate facilitates cancer cell adaptation to hypoxia by serving as an oxygen surrogate. Oncotarget 7 (2016), 47494–47510.
70. Zhang, J., Cao, J., Ma, S., Dong, R., Meng, W., Ying, M., Weng, Q., Chen, Z., Ma, J., Fang, Q., et al. Tumor hypoxia enhances non-small cell lung cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling. Oncotarget 5 (2014), 9664–9677.
71. Zhang, S., Hulver, M.W., McMillan, R.P., Cline, M.A., Gilbert, E.R., The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutr. Metab. (Lond), 11, 2014, 10.
72. Zhu, A., Lee, D., Shim, H., Metabolic positron emission tomography imaging in cancer detection and therapy response. Semin. Oncol. 38 (2011), 55–69.